HIV specific humoral immune response in Rio de Janeiro, Brazil

Bongertz, Vera; Costa, C. I; Guimaräes, M. L; Costa, M. F. G. Soares da; Grinsztejn, Beatriz; Santos, V. G. Veloso dos; Rolla, V. C; Cavalcante, Solange Cesar; Galhardo, M. C. G; Guimaräes, M. R. C; Khalili, R; Souza, Rogério Valls de; Bastos, Francisco Inácio; Pilotto, J. H. C; Joäo Filho, E. C; Loureiro, R; Chequer, P; Telles, P. R; Castro, Bernardo Galväo; Morgado, Mariza Gonçalves.
Mem. Inst. Oswaldo Cruz ; 93(3): 391-8, May-Jun. 1998. tab, graf
Artigo Inglês | LILACS | ID: lil-209963

Documentos relacionados

  1. A facile method of mapping HIV-1 neutralizing epitopes using chemically masked cysteines and deep sequencing.
  2. IL6 and FAS/FASL gene polymorphisms may be associated with disease progression in HIV-1-positive ethnically mixed patients.
  3. Large age shifts in HIV-1 incidence patterns in KwaZulu-Natal, South Africa.
  4. Dynamics and Correlates of CD8 T-Cell Counts in Africans with Primary Human Immunodeficiency Virus Type 1 Infection.
  5. Viral escape from neutralizing antibodies in early subtype A HIV-1 infection drives an increase in autologous neutralization breadth.
  6. Star nanoparticles delivering HIV-1 peptide minimal immunogens elicit near-native envelope antibody responses in nonhuman primates.
  7. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
  8. Comprehensive analysis of unique cases with extraordinary control over HIV replication.
  9. Selective use of primate CD4 receptors by HIV-1.
  10. The relationship between immunogenic red blood cell antigens and Human Immunodeficiency Virus infection.